about
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting ...
Read More
11.75
0.73
(6.62%)
360.4K
XNAS Volume
XNAS 07 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Immunic Inc is on 15 May 2026 for the purpose of Immunic Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Immunic Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..